Generating randomized trial evidence to optimize treatment in the COVID-19 pandemic
Matthew P. Cheng, Todd C. Lee, Darrell H. S. Tan, Srinivas Murthy
Abstract
KEY POINTS While aggressive mitigation strategies are being implemented to slow the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), we must also strive to optimize clinical outcomes for those infected and prevent transmission among their close contacts. As the number of
Topics & Concepts
Coronavirus disease 2019 (COVID-19)PandemicSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakRandomized controlled trialTransmission (telecommunications)CoronavirusBetacoronavirusMedicineIntensive care medicineKey (lock)Clinical trialCoronavirus InfectionsComputer scienceVirologyOutbreakInternal medicineComputer securityDiseaseInfectious disease (medical specialty)TelecommunicationsCOVID-19 Clinical Research StudiesCOVID-19 and healthcare impactsSARS-CoV-2 and COVID-19 Research